Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / LLY - Week In Review: Curon Bio Acquires Rights To Lymphoma Drug In $150 Million Deal


LLY - Week In Review: Curon Bio Acquires Rights To Lymphoma Drug In $150 Million Deal

  • HitGen will acquire Vernalis Limited, a Cambridge, UK CRO, from Ligand Pharmaceuticals for $25 million.
  • Singapore's ASLAN Pharmaceuticals announced plans to develop ASLAN003, its next-gen dihydroorotate dehydrogenase inhibitor in autoimmune conditions, such as multiple sclerosis.
  • PPD, a global CRO, announced plans to build a new laboratory in Suzhou to support China drug development.

For further details see:

Week In Review: Curon Bio Acquires Rights To Lymphoma Drug In $150 Million Deal
Stock Information

Company Name: Eli Lilly and Company
Stock Symbol: LLY
Market: NYSE
Website: lilly.com

Menu

LLY LLY Quote LLY Short LLY News LLY Articles LLY Message Board
Get LLY Alerts

News, Short Squeeze, Breakout and More Instantly...